Morphogenesis' Unattributed - II Round

Morphogenesis raised a round of funding on August 21, 2017.

Morphogenesis is a clinical stage company developing novel cell and gene therapies based on distinct and synergistic technology platforms. The company's mission is to change the way chronic diseases a…

Articles about Morphogenesis' Unattributed - II Round: